Ocular Prosthetics Lab is categorized under Artificial Human Eye Manufacturers in Orlando, FL and active since 1977.
Ocular Prosthetics Lab was established in 1977, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Artificial Human Eye Manufacturers business, which does work in the B2B market, and is classified as a Artificial Human Eye Manufacturers, under code number 0 by the NAICS.
If you are seeking more information, feel free to contact Rick Bowen at the company’s headquarters by writing to 36 W Illiana Street, Orlando, Florida FL 32806 or by phoning (407) 246-5451. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Ocular Prosthetics Lab |
| Contact Person: | Rick Bowen |
| Address: | 36 W Illiana Street, Orlando, Florida 32806 |
| Phone Number: | (407) 246-5451 |
| Website Address: | opleye.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 1977 |
| Location Type: | Headquarters |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Artificial Human Eye Manufacturers |
| SIC Code: | 0 |
| NAICS Code: | 0 |
| Share This Business: |
Ocular Prosthetics Lab was started in 1977 to provide professional Artificial Human Eye Manufacturers under the SIC code 0 and NAICS code 0. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Rick Bowen for inquiries that concern Ocular Prosthetics Lab by calling the company number (407) 246-5451, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Ocular Prosthetics Lab can be found at the coordinates 28.51258,-81.37912 as well as the street address 36 W Illiana Street in Orlando, Florida 32806.
For its online presence, you may visit Ocular Prosthetics Lab’s website at opleye.com and engage with its social media outlets through on Twitter and on Facebook.